Lack of a clinically relevant effect of an antacid on the pharmacokinetics of lersivirine.
about
Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerabilityEfavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer CellsClinically significant drug interactions with antacids: an update.Lersivirine - a new drug for HIV infection therapy.
P2860
Lack of a clinically relevant effect of an antacid on the pharmacokinetics of lersivirine.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Lack of a clinically relevant ...... armacokinetics of lersivirine.
@ast
Lack of a clinically relevant ...... armacokinetics of lersivirine.
@en
type
label
Lack of a clinically relevant ...... armacokinetics of lersivirine.
@ast
Lack of a clinically relevant ...... armacokinetics of lersivirine.
@en
prefLabel
Lack of a clinically relevant ...... armacokinetics of lersivirine.
@ast
Lack of a clinically relevant ...... armacokinetics of lersivirine.
@en
P2093
P356
P1476
Lack of a clinically relevant ...... armacokinetics of lersivirine.
@en
P2093
P304
P356
10.1128/AAC.01110-09
P407
P577
2010-02-16T00:00:00Z